Nevro touts data supporting use of Senza system to treat diabetic neuropathy pain

Nevro touts data supporting use of Senza system to treat diabetic neuropathy pain

Source: 
Mass Device
snippet: 

Nevro (NYSE:NVRO) today touted results from a trial of its Senza system for treating painful diabetic neuropathy (PDN)-related chronic pain.